Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
FDA adverse events reporting system (FAERS) public dashboard Forbes
Losing muscle compromises metabolic health and elevates the risk of weight regain post-medication
The clinical trial data from both Phase 2 (Jastreboff et al., NEJM 2023) and Phase 3 (TRIUMPH-4, Eli Lilly press release December 2025) provide a detailed picture of the weight loss trajectory over time
The cartilage/chondrocyte data supports this
Important: If any instructions on the vial label differ from the information below, the label instructions take priority
US$ 21.32
US$ 25.76
US$ 28.23
US$ 26.16
US$ 24.91
US$ 22.59
US$ 27.47
US$ 20.30
US$ 28.64
US$ 20.94
